ArticleOncology letters2026

Astragaloside IV suppresses triple-negative breast cancer cell migration and invasion by targeting BCAT1-mediated branched-chain amino acid metabolism.

Yi-Ting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.